Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2020 Jan 17.
Published in final edited form as: Tetrahedron Lett. 2018 Dec 19;60(3):322–326. doi: 10.1016/j.tetlet.2018.12.045

Synthesis of Fused Indolines by Interrupted Fischer Indolization in a Microfluidic Reactor

Alexander Tuan-Huy Duong 1, Bryan J Simmons 2, Mohammad Parvez Alam 1,§, Jesus Campagna 1, Neil K Garg 2,, Varghese John †,*
PMCID: PMC6322698  NIHMSID: NIHMS1517487  PMID: 30631216

Abstract

This study describes our development of a microfluidic reaction scheme for the synthesis of fused indoline ring systems found in several bioactive compounds. We have utilized a continuous-flow microfluidic reactor for the reaction of hydrazines with latent aldehydes through the interrupted Fischer indolization reaction to form fused indoline and azaindoline products. We have identified optimal conditions and evaluated the scope of this microfluidic reaction using various hydrazine and latent aldehyde surrogates. This green chemistry approach can be of general utility to rapidly produce indoline scaffolds and intermediates in a continuous manner.

Keywords: Flow chemistry, Interrupted Fischer Indolization, Microfluidic reactor, (Aza)indoline, Latent aldehyde

Graphical Abstract

graphic file with name nihms-1517487-f0003.jpg

Introduction

The discovery and development of efficient methods using microfluidic flow chemistry to rapidly synthesize bioactive molecules is of great value for hit-to-lead optimization efforts.13 However, microfluidic transformations of basic reactions are still limited due to engineering feasibility for translating heterogeneous reactions in a flow reactor.48 A vast majority of low molecular weight bioactive molecules are heterocyclic, and often comprised of several connected heterocyclic rings.911 A small subset of molecules that have received substantial interest due to their medicinal properties are furoindoline and pyrrolidinoindoline that possess a fused indoline motif as shown in Figure 1. These scaffolds are present in many naturally occurring alkaloids.1219

Figure 1.

Figure 1.

Example of representative bioactive compounds containing fused indolines.

The Fischer indolization reaction is an efficient way to construct fused indoline ring-systems, although several alternate methods have also been developed to access these biologically important motifs.19,20 A variant of this reaction, the Garg interrupted Fischer indolization, has the advantage of producing three new bonds, two heterocyclic rings and two stereogenic centers, in one reaction.15,16 This methodology is convergent, broad in scope, proceeds under mild reaction conditions, and can be used to synthesize a variety of natural products.15 In one such example this transformation has been recently utilized in the total synthesis of Aspidophylline A (3) and its aza analog.18,22

Continuous-flow microfluidic reactor based approaches allow for rapid synthesis of products in a green chemistry mode.2 While there are few reports on Fischer indolization reactions using a microfluidic reactor, this is not the case with the interrupted Fisher indolization reaction to the best of our knowledge.2325 We describe here the development of a microfluidic reactor process for the preparation of indoline and azaindoline compounds using the interrupted Fischer indolization reaction, which complements known batch chemistry (Scheme 1).15 This microfluidic reaction allows for the synthesis of indoline-containing products by the reaction of hydrazines and latent aldehydes under mildly acidic conditions. The methodology allows for efficient reagent mixing, smaller reaction volumes, optimal heat transfer, precise reaction (retention) times, and the possibility to conduct multistep reactions in a single or continuous sequence. Thus, this microfluidic approach can be of general utility for synthesis of such biologically relevant molecules in a safe, environmentally friendly, and cost effective manner that could be amenable to large scale manufacturing.

Synthetic Scheme 1.

Synthetic Scheme 1

Results and discussion

Our approach to obtain indoline scaffolds in the microfluidic reactor using the interrupted Fischer indole synthesis is shown in the scheme 1.15 As part of developing this transformation we initially tried the reaction of phenyl-hydrazine (4) and lactol (latent aldehyde) 5 in the reactor using (1:1) AcOHH2O at 60 °C and 1 bar pressure to determine if we could obtain furoindoline 6. Unfortunately, we did not get any product under these conditions. Next we changed the temperature, pressure and retention time in the microfluidic reactor to determine the reaction outcome. Next we systematically change temperature, pressure, and retention time in the microfluidic reactor to determine the reaction outcome. After several variations we found that successful interrupted Fischer indolization reaction occurred at 80 °C, 2 bar pressure, and 20 min retention time in the microfluidic reactor affording the desired furoindoline 6 in 84% yield (entry 5). Further increasing the temperature, pressure and retention time in the microfluidic reactor led to the optimal conditions of 120 °C, 3 bar pressure and 5 min retention time in the microfluidic reactor affording a 97% yield of 6 as determined by HPLC (entry 8). Scale up and purification gave 285 mg of furoindoline 6 in 65% isolated yield (details in supplementary information).

After identifying the optimal microfluidic conditions for the interrupted Fischer indolization, we next conducted the reaction using different hydrazines while keeping the latent aldehyde (5) constant. As shown in Table 2, the reaction is broad in scope with respect to the hydrazine surrogates. Both para- and ortho- substituents were tolerated under the microfluidic reaction condition (entries 1, 2, 4, 5 and 6) and afforded the corresponding furoindoline products in good yields. The N-methyl-substituted hydrazine 9 was shown to be a competent coupling partner (entry 3) and afforded the desired N-methyl furoindoline 16 in 68% yield while use of the p-methoxypyridylhydrazine salt 13 afforded the furanoazaindoline 20 in moderate 40% yield (entry 7). Several of the products such as the haloindolines (entries 2, 5, 6), are setup for further functionalization by transition-metal-catalyzed cross-coupling chemistry.

Table 2.

Hydrazine variants in the microfluidic interrupted Fischer indolization reactiona

graphic file with name nihms-1517487-t0005.jpg

Entry Hydrazine Variant Product Yield

1 graphic file with name nihms-1517487-t0006.jpg graphic file with name nihms-1517487-t0013.jpg 78%
2 graphic file with name nihms-1517487-t0007.jpg graphic file with name nihms-1517487-t0014.jpg 57%
3 graphic file with name nihms-1517487-t0008.jpg graphic file with name nihms-1517487-t0015.jpg 68%
4 graphic file with name nihms-1517487-t0009.jpg graphic file with name nihms-1517487-t0016.jpg 34%
5 graphic file with name nihms-1517487-t0010.jpg graphic file with name nihms-1517487-t0017.jpg 55%
6 graphic file with name nihms-1517487-t0011.jpg graphic file with name nihms-1517487-t0018.jpg 56%
7 graphic file with name nihms-1517487-t0012.jpg graphic file with name nihms-1517487-t0019.jpg 40%
a

The reactions were performed using optimized condition (see Table 1, entry 8);two solutions were prepared and introduced by Pump A & B into the Asia microfluidic reactor; one contained the different hydrazine surrogates (713) (1.0 equivalent) in AcOH–H2O (2.5 mL, 1:1 v/v) and the other contained latent aldehyde 5 (1.1 equivalent) in AcOH–H2O (2.5 mL, 1:1 v/v). Average isolated yields from at least two trials for products (1420) are reported.

We further evaluated the scope of the transformation with nitrogen- or oxygen-containing latent aldehyde coupling partners using phenyl hydrazine 4 (Table 3). The use of five- membered oxygen- or nitrogen-containing latent aldehydes, under more dilute conditions for solubility, afforded the corresponding furoindoline 24 and pyrrolidinoindoline 25 in 49% and 42% yield, respectively. Interestingly, even the six-membered homolog (26) of the pyrrolidinoindoline framework was obtained using this methodology, although in lower yield.

Table 3.

Variations of the latent aldehyde surrogate in the microfluidic reaction a

graphic file with name nihms-1517487-t0020.jpg

Entry Lactol Variant Product Yield

1b graphic file with name nihms-1517487-t0021.jpg graphic file with name nihms-1517487-t0024.jpg 49%
2c graphic file with name nihms-1517487-t0022.jpg graphic file with name nihms-1517487-t0025.jpg 42%
3d graphic file with name nihms-1517487-t0023.jpg graphic file with name nihms-1517487-t0026.jpg 21%
a

The reactions were performed using optimized conditions (see Table 1, entry 8); two solutions were prepared and introduced by Pump A & B into the Asia microfluidic reactor; one contained the phenyl hydrazine (4) (1.0 equivalent) in AcOH–H2O (0.5 mL, 1:1 v/v) and the other contained lactol variant (2123) (1.1 equivalent) in AcOH–H2O or AcOH (0.5 mL, 1:1 v/v). Average isolated yields from at least two trials for products (2426) are reported.

b

Hydrazine added at 0.4 M. Latent aldehyde at 1.1 equivalent due to insolubility of latent aldehyde 21.

c

Hydrazine added at 0.1 M. Latent aldehyde at 1.1 equivalent due to insolubility of latent aldehyde 22.

d

Hydrazine added at 0.4 M. Latent aldehyde at 1.1 equivalent due to insolubility of latent aldehyde 23 & reaction performed in AcOH.

Conclusion

The use of a microfluidic reactor for the interrupted Fischer indolization resulted in short reaction times and led to indoline and azaindoline products in reasonable yields. We were able to accelerate the microfluidic reaction by increasing temperature and pressure to achieve yields upto 97% with 5 minutes residence time in the reactor. This rapid green chemistry methodology should facilitate continuous synthesis of fused indoline ring systems that can potentially be coupled with additional microfluidic reactors for multistep synthesis. This approach allows for rapid synthesis of these important scaffolds as dual enzyme inhibitors and should prove useful for the discovery of new drug candidates.

Supplementary Material

1

Table 1.

Optimization of interrupted Fischer indolization in a microfluidic reactora

graphic file with name nihms-1517487-t0004.jpg

Entry Pressure (bar) Temperature (°C) Flow Rateb (μL/min) Retention Timec (min) Yieldd (%)

1e 1 60 500 2 0
2e 2 70 500 2 0
3e 2 70 200 5 0
4e 2 80 200 5 0
5e 2 80 50 20 84
6e 2 100 50 20 97
7f 3 120 100 10 97
8f 3 120 200 5 97g
a

Synthesis of compound 6 was done under varying conditions (entry 1 – 8); two solutions were prepared and introduced by Pump A & B into the Asia microfluidic reactor; one contained the phenyl hydrazine 4 (1.0 equivalent) in AcOH–H2O (2.5 mL, 1:1 v/v) and the other contained latent aldehyde 5 (1.1 equivalent) in AcOH–H2O (2.5 mL, 1:1 v/v).

b

Combined flow rate from both pumps.

c

Residence time in microfluidic chip reactor (1000 μL volume).

d

HPLC yield from microfluidic flow reactor.

e

Hydrazine added at 0.2 M. Latent aldehyde at 1.1 eqiv.

f

Hydrazine added at 0.5 M. Latent aldehyde at 1.1 eqiv.

g

Scale-up of reaction yielded furoindoline 6 in 65% yield.

Highlights:

  • Development of microfluidic reaction scheme for synthesis of fused indoline ring systems by flow chemistry

  • Green chemistry approach with clean reaction profile, good yields and quick scalability.

  • Continuous-flow in a microfluidic reactor for interrupted Fischer indolization reaction.

  • General utility to rapidly produce indoline scaffolds and intermediates of industrial importance

Acknowledgements

This research was supported by the Mary S. Easton Center for Alzheimer’s disease Research at UCLA to V.J., and NIH Grant (AG051386 to V.J.), and the National Science Foundation (DGE-1144087 for B.J.S. and CHE-1464898 for N.K.G.) Mass Spectrometry Instrumentation was made available through the support of Dr. Greg Khitrov and Dr. Yu Chen at the University of California, Los Angeles Molecular Instrumentation Center – Mass Spectrometry Facility in the Department of Chemistry. These studies were supported by shared instrumentation grants from the NSF (CHE-1048804) and the National Center for Research Resources (S10RR025631).

Footnotes

The authors declare no competing financial interest.

ASSOCIATED CONTENT

Supplementary Data

Supplementary data (1H and 13C NMR spectra for all new compounds) associated with this article can be found, in the online version, at http:/dx.doi.org/

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References and notes

  • (1).Polshettiwar V; Varma RS Curr. Opin. Drug Discov. Devel 2007, 10, 723. [PubMed] [Google Scholar]
  • (2).(a) Lummiss JAM; Morse PD; Beingessner RL; Jamison TF. Chem. Rec 2017, 17, 667. [DOI] [PubMed] [Google Scholar]; (b) Alam MP; Jagodzinska B; Campagna J; Spilman P; John V Tetrahedron Lett. 2016, 57, 2059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (3).Brzozowski M; O’Brien M; Ley SV; Polyzos A Acc. Chem. Res 2015, 48, 349. [DOI] [PubMed] [Google Scholar]
  • (4).Flow Chemistry; Dar as,.; essel V; Dorm n, G., Eds.; De Gruyter: Berlin, 2014; Vols. 1 &2. [Google Scholar]
  • (5).Fanelli F; Parisi G; Degennaro L; Luisi R Beilstein J. Org. Chem 2017, 13, 520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (6).Gérardy R; Emmanuel N; Toupy T; Kassin V-E; Tshibalonza NN; Schmitz M; Monbaliu J-CM Eur. J. Org. Chem 2018, 2018, 2301. [Google Scholar]
  • (7).Hartman RL; McMullen JP; Jensen KF Angew. Chemie Int. Ed 2011, 50, 7502. [DOI] [PubMed] [Google Scholar]
  • (8).Pieber B; Gilmore K; Seeberger PH J. Flow Chem 2017, 7, 129. [DOI] [PubMed] [Google Scholar]
  • (9).Myers RM; Fitzpatrick DE; Turner RM; Ley SV Chem. - A Eur. J 2014, 20, 12348. [DOI] [PubMed] [Google Scholar]
  • (10).Gutmann B; Cantillo D; Kappe CO Angew. Chem. Int. Ed 2015, 54, 6688. [DOI] [PubMed] [Google Scholar]
  • (11).Baumann M; Baxendale IR Beilstein J. Org. Chem 2015, 11, 1194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (12).Klein J Phenserine. Expert Opin. Investig. Drugs 2007, 16, 1087. [DOI] [PubMed] [Google Scholar]
  • (13).Sunazuka T; Hirose T; Shirahata T; Harigaya Y; Hayashi M; Komiyama K; Omura S; Smith AB J. Am. Chem. Soc 2000, 122, 2122. [Google Scholar]
  • (14).Ren W; Wang Q; Zhu J Chem.- Int. Ed 2014, 53, 1818. [DOI] [PubMed] [Google Scholar]
  • (15).Boal BW; Schammel AW; Garg NK Org. Lett 2009, 11, 3458. [DOI] [PubMed] [Google Scholar]
  • (16).or a pertinent re iew of the Garg laboratory’s ischer indolization studies, see: Susick RB; Morrill LA; Picazo E; Garg NK. Synlett 2017, 28, 1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (17).Schammel AW; Boal BW; Zu L; Mesganaw T; Garg NK Tetrahedron 2010, 66, 4687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (18).Simmons BJ; Hoffmann M; Champagne PA; Picazo E; Yamakawa K; Morrill LA; Houk KN; Garg NK J. Am. Chem. Soc 2017, 139, 14833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (19).Flow Chemistry for the Synthesis of Heterocycles; Van Mileghem S; Veryser C; De Borggraeve WM; Sharma UK, Eds; Van der Eycken EV, Eds. Springer: Cham, 2018; pp 133–159. [Google Scholar]
  • (20).Fischer E; Jourdan F Ueber Die Hydrazine Der Brenztraubensäure. Berichte der Dtsch. Chem. Gesellschaft 1883, 16, 2241. [Google Scholar]
  • (21).Fischer E; Hess O Berichte der Dtsch. Chem. Gesellschaft 1884, 17, 559. [Google Scholar]
  • (22).Zu L; Boal BW; Garg NK J. Am. Chem. Soc 2011, 133, 8877. [DOI] [PubMed] [Google Scholar]
  • (23).Gutmann B; Gottsponer M; Elsner P; Cantillo D; Roberge DM; Kappe CO Org. Process Res. Dev 2013, 17, 294. [Google Scholar]
  • (24).Wahab B; Ellames G; Passey S; Watts P Tetrahedron 2010, 66, 3861. [Google Scholar]
  • (25).Xu J; Yu J; Jin Y; Li J; Yu Z; Lv Y Chem. Eng. Process. Process Intensif 2017, 121, 144. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

RESOURCES